|
gptkbp:instanceOf
|
person
|
|
gptkbp:affiliation
|
gptkb:University_of_Texas_MD_Anderson_Cancer_Center
|
|
gptkbp:awards
|
FDA_Commissioner’s_Special_Citation
|
|
gptkbp:birthDate
|
1960-07-24
|
|
gptkbp:birthPlace
|
gptkb:Pittsburgh,_Pennsylvania
|
|
gptkbp:children
|
2
|
|
gptkbp:education
|
gptkb:Medical_College_of_Wisconsin
gptkb:University_of_California,_San_Diego
|
|
gptkbp:field
|
oncology
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Stephen Hahn
|
|
gptkbp:influencedBy
|
gptkb:Scott_Gottlieb
gptkb:David_A._Kessler
|
|
gptkbp:knownFor
|
COVID-19 response
|
|
gptkbp:nationality
|
American
|
|
gptkbp:notableWork
|
Regulatory science initiatives
Emergency Use Authorization for COVID-19 vaccines
|
|
gptkbp:occupation
|
physician
medical researcher
|
|
gptkbp:positionHeld
|
Commissioner_of_the_Food_and_Drug_Administration
|
|
gptkbp:predecessor
|
gptkb:Scott_Gottlieb
|
|
gptkbp:researchFocus
|
cancer treatment
radiation oncology
|
|
gptkbp:retired
|
January 2021
|
|
gptkbp:spouse
|
gptkb:Kathy_Hahn
|
|
gptkbp:successor
|
Janet Woodcock
|
|
gptkbp:termEnd
|
January 2021
|
|
gptkbp:termStart
|
December 2019
|